Long-acting HIV shots appeal to many but uptake remains low
When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living with HIV in Boston, Chapel Hill, N.C., and San Diego, 68% of respondents sa
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · US
- [CONFLICT] ABD'nin savaş hazırlıkları sürüyor! Orta Doğu'ya 3'üncü uçak gemisi
- [FINANCE] Intel's stock soars 15% as results top estimates, with chipmaker showing signs of growth
- [FINANCE] US stocks fall on a shaky Wall Street as Brent oil briefly barrels above $107 - The Edwardsville Intelligencer
- [FINANCE] Fed’s Bowman Cautions Wall Street CEOs Against Capital Gripes
- [CONFLICT] First Industrial forecasts $3.05-$3.15 2026 NAREIT FFO per share as Phoenix $131M land sale is expected to close in June
- [FINANCE] Cheap stock options suggest a big post-earnings swing next week for these tech titans